Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

28 August 2012: UCL to launch world’s biggest ‘living lab’ to support tech and media start-ups

UCL, along with partners in the technology and media industries, is launching a new service for digital and media start-ups that is intended to be the world’s largest ‘living lab’ for entrepreneurs. 
More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>